Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress
Elizabeth F. Krakow(Fred Hutch Cancer Center), Marie Bleakley(Unknown), Kyle B. Woodward(Jackson Memorial Hospital), Melinda A. Biernacki(Fred Hutch Cancer Center), Ann Dahlberg(Seattle Children's Hospital), Robson G. Dossa(Fred Hutch Cancer Center), Tsadik Habtetsion(Fred Hutch Cancer Center), Michelle Brault(Fred Hutch Cancer Center), Megan Hickner(Fred Hutch Cancer Center), Nicole Vartanian(Fred Hutch Cancer Center), Merav Bar(Fred Hutch Cancer Center), Corinne Summers(Seattle Children's Hospital), Tanya Cunningham(Fred Hutch Cancer Center), Colette Chaney(Fred Hutch Cancer Center)
Cited by 6
Related Papers
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2021|180
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
|Bone Marrow Transplantation|2019|119
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia
|Journal of Clinical Investigation|2020|111
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy
|Biology of Blood and Marrow Transplantation|2018|106
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2017|87